274 related articles for article (PubMed ID: 16763974)
1. Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?
Gronchi-Perrin A; Viollier S; Ghika J; Combremont P; Villemure JG; Bogousslavsky J; Burkhard PR; Vingerhoets F
Mov Disord; 2006 Sep; 21(9):1465-8. PubMed ID: 16763974
[TBL] [Abstract][Full Text] [Related]
2. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
[TBL] [Abstract][Full Text] [Related]
3. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E
Mov Disord; 2007 May; 22(7):990-7. PubMed ID: 17443692
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease.
Erola T; Heikkinen ER; Haapaniemi T; Tuominen J; Juolasmaa A; Myllylä VV
Acta Neurochir (Wien); 2006 Apr; 148(4):389-94. PubMed ID: 16284705
[TBL] [Abstract][Full Text] [Related]
5. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.
Volkmann J; Albanese A; Kulisevsky J; Tornqvist AL; Houeto JL; Pidoux B; Bonnet AM; Mendes A; Benabid AL; Fraix V; Van Blercom N; Xie J; Obeso J; Rodriguez-Oroz MC; Guridi J; Schnitzler A; Timmermann L; Gironell AA; Molet J; Pascual-Sedano B; Rehncrona S; Moro E; Lang AC; Lozano AM; Bentivoglio AR; Scerrati M; Contarino MF; Romito L; Janssens M; Agid Y
Mov Disord; 2009 Jun; 24(8):1154-61. PubMed ID: 19412954
[TBL] [Abstract][Full Text] [Related]
7. Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.
Mercado R; Constantoyannis C; Mandat T; Kumar A; Schulzer M; Stoessl AJ; Honey CR
Mov Disord; 2006 Sep; 21(9):1457-61. PubMed ID: 16721750
[TBL] [Abstract][Full Text] [Related]
8. The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease.
Nazzaro JM; Pahwa R; Lyons KE
Parkinsonism Relat Disord; 2011 Sep; 17(8):606-9. PubMed ID: 21669545
[TBL] [Abstract][Full Text] [Related]
9. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Yamada K; Goto S; Hamasaki T; Kuratsu JI
Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
[TBL] [Abstract][Full Text] [Related]
10. Apraxia of eyelid opening after subthalamic deep brain stimulation may be caused by reduction of levodopa.
Umemura A; Toyoda T; Yamamoto K; Oka Y; Ishii F; Yamada K
Parkinsonism Relat Disord; 2008 Dec; 14(8):655-7. PubMed ID: 18316231
[TBL] [Abstract][Full Text] [Related]
11. Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus.
Østergaard K; Aa Sunde N
Mov Disord; 2006 May; 21(5):624-31. PubMed ID: 16283616
[TBL] [Abstract][Full Text] [Related]
12. Subthalamic nucleus stimulation applied in the earlier vs. advanced stage of Parkinson's disease - retrospective evaluation of postoperative independence in pursuing daily activities.
Yamada K; Hamasaki T; Kuratsu J
Parkinsonism Relat Disord; 2009 Dec; 15(10):746-51. PubMed ID: 19481492
[TBL] [Abstract][Full Text] [Related]
13. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
[TBL] [Abstract][Full Text] [Related]
14. Two cases of unexpected long-term improvement of Parkinson's disease after subthalamic nucleus deep brain stimulation removal.
Wong SH; Eldridge PR; Duffy A; Fox SH; Varma TR; Fletcher NA
Br J Neurosurg; 2011 Apr; 25(2):281-3. PubMed ID: 21344961
[TBL] [Abstract][Full Text] [Related]
15. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
Lyons KE; Davis JT; Pahwa R
Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
[TBL] [Abstract][Full Text] [Related]
16. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
[TBL] [Abstract][Full Text] [Related]
17. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long-term follow-up.
Tavella A; Bergamasco B; Bosticco E; Lanotte M; Perozzo P; Rizzone M; Torre E; Lopiano L
Neurol Sci; 2002 Sep; 23 Suppl 2():S111-2. PubMed ID: 12548368
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease.
Siderowf A; Jaggi JL; Xie SX; Loveland-Jones C; Leng L; Hurtig H; Colcher A; Stern M; Chou KL; Liang G; Maccarone H; Simuni T; Baltuch G
Mov Disord; 2006 Jun; 21(6):746-53. PubMed ID: 16463342
[TBL] [Abstract][Full Text] [Related]
19. MEP latency shift after implantation of deep brain stimulation systems in the subthalamic nucleus in patients with advanced Parkinson's disease.
Hidding U; Bäumer T; Siebner HR; Demiralay C; Buhmann C; Weyh T; Moll C; Hamel W; Münchau A
Mov Disord; 2006 Sep; 21(9):1471-6. PubMed ID: 16703590
[TBL] [Abstract][Full Text] [Related]
20. Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.
Wider C; Russmann H; Villemure JG; Robert B; Bogousslavsky J; Burkhard PR; Vingerhoets FJ
Arch Neurol; 2006 Jul; 63(7):951-5. PubMed ID: 16831963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]